Direktorat Registrasi ObatValid

PIROXICAM

Claim this product
BPOM Number
GKL9732701110A1
Approved
6 April 2026
Expiry
2 June 2027
Form
Tablet

About This Registration

PIROXICAM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL9732701110A1. Its current registration status is Valid, with the licence valid until 2 June 2027. The product is registered to YARINDO FARMATAMA and manufactured by YARINDO FARMATAMA - INDONESIA. BPOM first approved this registration in March 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 10 STRIP @ 10 TABLET
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

PIROXICAM

Market Intelligence

Owner Portfolio
YARINDO FARMATAMA holds 137 BPOM registrations
Manufacturer Scale
YARINDO FARMATAMA - INDONESIA produces 122 registered products
Registration Age
Registered for 3 months
Expiry Status
Expires in 10 months

FDA Cross-Reference

via openFDA
Generic Name
PIROXICAM
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from YARINDO FARMATAMA

GLUDEPATIC 500

-DKL2632724417A1
Valid
Approved: Apr 10, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717B1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717A1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

ARIPIPRAZOLE

-GKL2532723035A2
Valid
Approved: Dec 31, 2025CAIRAN ORAL
View product →

VERDON

-DKL2532723917A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
View product →

Products in the same class

QUETIAPINE FUMARATE

-GKL2643501014C1
Valid
Approved: Mar 31, 2026TABLET PELEPASAN LAMBAT
AMAROX PHARMA GLOBAL - INDONESIA
View product →

EMPAFER

-DKL2634617717A1
Valid
Approved: Mar 16, 2026TABLET SALUT SELAPUT
FERRON PAR PHARMACEUTICALS
View product →

ATORVASTATIN CALCIUM TRIHYDRATE

-GKL2513615117A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
LUCAS DJAJA - INDONESIA
View product →

AZOVIR

-DKL9714809429A1
Valid
Approved: Dec 12, 2025KRIM
MEDIKON PRIMA LABORATORIES - INDONESIA
View product →

ANTALAM

-DBL2003605033A1
Valid
Approved: Dec 1, 2025SUSPENSI
CANDRA NUSANTARA JAYA - INDONESIA
View product →
1